Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Gastroenterology
Published in: Current Treatment Options in Gastroenterology 3/2016

01-09-2016 | Intractable Disease in the Elderly: When Conventional Therapy Fails (S Katz, Section Editor)

Endoscopy in the Elderly: a Cautionary Approach, When to Stop

Authors: Rita Abdelmessih, MD, Christopher D. Packey, MD, PhD, Garrett Lawlor, MD

Published in: Current Treatment Options in Gastroenterology | Issue 3/2016

Login to get access

Opinion statement

Performing endoscopic procedures in the elderly carries known enhanced risk compared to the general population. Weighing the benefits against the risks is easy when a patient is in immediate danger, but a gray area arises in screening protocols in an elderly patient of average risk. In this review, we compare national and international guidelines in average risk screening procedures (colonoscopic colorectal screening, Barrett’s surveillance) to find consensus for screening practice in the elderly. With minor differences between societal guidelines, it is widely agreed that 75 years is the appropriate age to begin to weigh risks and benefits according to a patient’s state of health and comorbidities. For colorectal screening, most guidelines advocate complete cessation of screening after the age of 85 years. Such consensus must take into account an aging population where patients are living healthier for longer and thus may be appropriate candidates for screening procedures even if beyond designated ages of screening cessation.
Literature
1.
Adolph RJ. The elderly, the very elderly and traditional practice patterns. J Am Coll Cardiol. 1990;16(4):793–4.PubMedCrossRef
2.
Travis AC, Pievsky D, Saltzman JR. Endoscopy in the elderly. Am J Gastroenterol. 2012;107(10):1495–501. quiz 1494, 1502.PubMedCrossRef
3.
Stein HJ, Siewert JR. Barrett’s esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia. 1993;8(3):276–88.PubMedCrossRef
4.
Cameron AJ, Souto EO, Smyrk TC. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia. Am J Gastroenterol. 2002;97(6):1375–80.PubMedCrossRef
5.
Portale G et al. Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without barrett mucosa. Arch Surg. 2005;140(6):570–4. discussion 574-5.PubMedCrossRef
6.
Wang KK, Sampliner RE, G. Practice Parameters Committee of the American College of. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103(3):788–97.PubMedCrossRef
7.
8.
Cameron AJ et al. Adenocarcinoma of the esophagogastric junction and Barrett’s esophagus. Gastroenterology. 1995;109(5):1541–6.PubMedCrossRef
9.
Cameron AJ et al. Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology. 1990;99(4):918–22.PubMedCrossRef
10.
Hage M et al. Oesophageal cancer incidence and mortality in patients with long-segment Barrett’s oesophagus after a mean follow-up of 12.7 years. Scand J Gastroenterol. 2004;39(12):1175–9.PubMedCrossRef
11.
Sikkema M et al. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8(3):235–44. quiz e32.PubMedCrossRef
12.
13.
Csendes A et al. Prevalence of Barrett’s esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Dis Esophagus. 2000;13(1):5–11.PubMedCrossRef
14.
Hvid-Jensen F et al. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365(15):1375–83.PubMedCrossRef
15.
Caygill CP et al. A single centre’s 20 years’ experience of columnar-lined (Barrett’s) oesophagus diagnosis. Eur J Gastroenterol Hepatol. 1999;11(12):1355–8.PubMedCrossRef
16.
Yousef F et al. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008;168(3):237–49.PubMedCrossRef
17.
Armstrong D et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults—update 2004. Can J Gastroenterol. 2005;19(1):15–35.PubMedCrossRef
18.
American Gastroenterological A et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140(3):1084–91.CrossRef
19.
Boyer J et al. French Society of Digestive Endoscopy SFED guideline: monitoring of patients with Barrett’s esophagus. Endoscopy. 2007;39(9):840–2.PubMedCrossRef
20.
Hirota WK et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63(4):570–80.PubMedCrossRef
21.
Committee, A.S.o.P. et al. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76(6):1087–94.CrossRef
22.•
Fitzgerald RC et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42. Most recent guidelines from the British Society of Gastroenterology.PubMedCrossRef
23.•
Sharma P et al. Quality indicators for the management of Barrett’s esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. Gastroenterology. 2015;149(6):1599–606. Most recent guidelines from the American Gastroenterological Association.PubMedPubMedCentralCrossRef
24.
Ladas SD et al. Ethical issues in endoscopy: patient satisfaction, safety in elderly patients, palliation, and relations with industry. Second European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, July 2006. Endoscopy. 2007;39(6):556–65.PubMedCrossRef
25.
Committee, A.S.o.P. et al. Modifications in endoscopic practice for the elderly. Gastrointest Endosc. 2013;78(1):1–7.CrossRef
26.
Theocharis GJ et al. Acute upper gastrointestinal bleeding in octogenarians: clinical outcome and factors related to mortality. World J Gastroenterol. 2008;14(25):4047–53.PubMedPubMedCentralCrossRef
27.
Van Kouwen MC et al. Upper gastrointestinal endoscopy in patients aged 85 years or more. Results of a feasibility study in a district general hospital. Arch Gerontol Geriatr. 2003;37(1):45–50.PubMedCrossRef
28.
Seinela L et al. Reasons for and outcome of upper gastrointestinal endoscopy in patients aged 85 years or more: retrospective study. BMJ. 1998;317(7158):575–80.PubMedPubMedCentralCrossRef
29.
Clarke GA et al. The indications, utilization and safety of gastrointestinal endoscopy in an extremely elderly patient cohort. Endoscopy. 2001;33(7):580–4.PubMedCrossRef
30.
Lee TC et al. Age is not a discriminating factor for outcomes of therapeutic upper gastrointestinal endoscopy. Hepatogastroenterology. 2007;54(77):1319–22.PubMed
31.
Lockhart SP et al. Upper gastrointestinal endoscopy in the elderly. Br Med J (Clin Res Ed). 1985;290(6464):283.CrossRef
32.
Muravchick S. The elderly outpatient: current anesthetic implications. Curr Opin Anaesthesiol. 2002;15(6):621–5.PubMedCrossRef
33.
Abraham NS et al. Sedation versus no sedation in the performance of diagnostic upper gastrointestinal endoscopy: a Canadian randomized controlled cost-outcome study. Am J Gastroenterol. 2004;99(9):1692–9.PubMedCrossRef
34.
35.
Dumortier J et al. Unsedated transnasal EGD in daily practice: results with 1100 consecutive patients. Gastrointest Endosc. 2003;57(2):198–204.PubMedCrossRef
36.
Garcia RT et al. Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: a multicenter randomized trial. Gastroenterology. 2003;125(6):1606–12.PubMedCrossRef
37.
Howlander N. SEER cancer statistics review, 1975–2012. Bethesda: National Cancer Institute; 2015.
38.
Harewood GC, Lawlor GO. Incident rates of colonic neoplasia according to age and gender: implications for surveillance colonoscopy intervals. J Clin Gastroenterol. 2005;39(10):894–9.PubMedCrossRef
39.
Harewood GC, Lawlor GO, Larson MV. Incident rates of colonic neoplasia in older patients: when should we stop screening? J Gastroenterol Hepatol. 2006;21(6):1021–5.PubMedCrossRef
40.
Maheshwari S, Patel T, Patel P. Screening for colorectal cancer in elderly persons: who should we screen and when can we stop? J Aging Health. 2008;20(1):126–39.PubMedCrossRef
41.
Kahi CJ et al. Survival of elderly persons undergoing colonoscopy: implications for colorectal cancer screening and surveillance. Gastrointest Endosc. 2007;66(3):544–50.PubMedCrossRef
42.
Ko CW, Sonnenberg A. Comparing risks and benefits of colorectal cancer screening in elderly patients. Gastroenterology. 2005;129(4):1163–70.PubMedCrossRef
43.
44.
Lee DW et al. Patient-controlled sedation versus intravenous sedation for colonoscopy in elderly patients: a prospective randomized controlled trial. Gastrointest Endosc. 2002;56(5):629–32.PubMedCrossRef
45.
46.
47.
Inadomi JM, Sonnenberg A. The impact of colorectal cancer screening on life expectancy. Gastrointest Endosc. 2000;51(5):517–23.PubMedCrossRef
48.
Terret C et al. Effects of comorbidity on screening and early diagnosis of cancer in elderly people. Lancet Oncol. 2009;10(1):80–7.PubMedCrossRef
49.
Lieberman DA et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143(3):844–57.PubMedCrossRef
50.
Cairns SR et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666–89.PubMedCrossRef
51.
Qaseem A et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med. 2012;156(5):378–86.PubMedCrossRef
52.
Care, C.T.F.o.P.H. Recommendations on screening for colorectal cancer in primary care. CMAJ. 2016;188(5):340–8.CrossRef
53.
Leddin DJ et al. Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Can J Gastroenterol. 2010;24(12):705–14.PubMedPubMedCentralCrossRef
54.
von Karsa L, Patnick J, Segnan N. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition—Executive summary. Endoscopy. 2012;44 Suppl 3:SE1–8.
Metadata
Title
Endoscopy in the Elderly: a Cautionary Approach, When to Stop
Authors
Rita Abdelmessih, MD
Christopher D. Packey, MD, PhD
Garrett Lawlor, MD
Publication date
01-09-2016
Publisher
Springer US
Published in
Current Treatment Options in Gastroenterology / Issue 3/2016
Print ISSN: 1092-8472
Electronic ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-016-0101-3

Other articles of this Issue 3/2016

Current Treatment Options in Gastroenterology 3/2016 Go to the issue

Pancreas (T Stevens, Section Editor)

Preventing Post-ERCP Pancreatitis: Update 2016

Intractable Disease in the Elderly: When Conventional Therapy Fails (S Katz, Section Editor)

Managing Esophageal Dysphagia in the Elderly

Pancreas (T Stevens, Section Editor)

Interventional Pain Management Approaches for Control of Chronic Pancreatic Pain

Pancreas (T Stevens, Section Editor)

Role of ERCP in Patients With Idiopathic Recurrent Acute Pancreatitis

Intractable Disease in the Elderly: When Conventional Therapy Fails (S Katz, Section Editor)

Management of Inflammatory Bowel Disease in the Elderly

Pancreas (T Stevens, Section Editor)

Management of Disconnected Pancreatic Duct Syndrome
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits